Lamivudine treatment of advanced and decompensated liver disease due to hepatitis B

Hepato-Gastroenterology

Volumn 44, Issue 15, 1997, Pages 808-812

  Van Thiel, David H ^a,b   Friedlander, Lois ^b   Kania, Robert J ^b   Molloy, Peter J ^b   Hassanein, Tarek ^c   Wahlstrom, Eric ^c   Faruki, Hawazin ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b WESTERN PENNSYLVANIA HOSPITAL   (United States)

^c LOMA LINDA UNIVERSITY   (United States)

^d Central Blood Bank   (United States)

Author keywords

Advanced decompensated liver disease; Hepatitis B; Lamivudine; Liver transplant

Indexed keywords

LAMIVUDINE;

ADULT; ALLOGRAFT; ARTICLE; CHOLESTATIC HEPATITIS; CHRONIC HEPATITIS; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEPATITIS B; HEPATITIS VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS REPLICATION;

ADULT; AGED; ANTIVIRAL AGENTS; CHRONIC DISEASE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0030989328     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kane MA. Progress on the control of hepatitis B infection through immunisation. But. 1998; 34 (2 Suppl): S10-2.
2. Seeff LB, Koff RS. Evaluating concepts of the clinical and serologic consequences of hepatitis B virus infection. Semin Liver Dis. 1980; 6: 11-22.
3. Stemmel W, Schwarzendrube J, Nederou C, Strohmeyer G. Epidemiology, clinical course and treatment of chronic viral hepatitis. Hepato-Gastroenterology. 1991; 31: 22-34.
4. Weissberg JI, Andres LL, Smith CI, Weick S, Nichols JE, Garcia G, et al. Survival in chronic hepatitis B. An analysis of 379 patients. Ann Intern Med. 1984; 101: 613-6.
5. De Jongh FE, Janssen HL, De Man RA, Hop WC, Schalm SW, Van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology. 1992; 103: 1630-5.
6. Beasley RP, Wong L, Lin C, et al. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,700 men in Taiwan. Lancet 1981; 2: 1129-1132.
7. Wong DK, Cheung AM, O'Rourke K, Naylor CD, Detsky AS, Heathcole J. Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis. Ann Intern Med. 1993; 119: 312-23.
8. Hoofnagle JH, Di Bisceglie AM, Waggoner JG, Park Y. Liver, pancreas and biliary tract: Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. Gastroenterology. 1993; 104: 1116-1121.
9. Van Thiel DH, Fagiuoli S, Caraceni P, Carroll P, Deal SR, Gavaler JS. Rationale and Experience with FK 506 in the Treatment of IBD. In: Falk Symposium No. 76: Inflammatory Bowel Disease, Monteiro F, Veloso FT, (eds) Kluwer Academic Publishers, Lancaster, England, 1995, 192-202.
10. Doong SL, Tsai CH, Schinazi RF, Liotta DC, Cheng YC. Inhibition of the replication of hepatitis B virus in vitro by 2′, 3′ -dideoxy-3′-thiacytidine and related analogues. Proc Natl Acad Sci USA. 1991; 88: 8495-9.
11. Tyrrell DL, Fischer K, Savani K, Tan W, Jewell L. Treatment of chimpanzees and ducks hepatitis with lamivudine, 2′,3′dideoxy 3′thiacytidine, results in a rapid suppression of hepaviral DNA in sera. Clin Invest Med. 1993; 16(Suppl 4): B77.
12. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. Preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 1995; 333: 1657-61.
13. Benhamou Y, Katlama C, Lunel F, Coutellier A, Dohin E, Hamm N, Tubiana R, Gerson S, Poynard T, Opolon P. Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann Intern Med. 1996; 125: 707-712.
14. Van Leeuwen R, Katlama C, Kitchen V, Boucher CA, Tubiana R, McBride M, et al. Evaluation of safety and efficacy of 3TC (lamivudine) in patients with asymptomatic or mildly symptomatic human immunodeficiency virus infection: a phase VII study. J Infect Dis. 1995; 171: 1166-71.
15. Chang CN, Skalski V, Zhou JH, Cheng YC. Biochemical pharmacology of (+)- and (-)-2′,3′-dideoxy-3′-thiacytidine as anti-hepatitis B virus agents. J Biol Chem. 1992; 267: 22414-20.
16. Ashman C, Larkin D, Cammack N, Boehme RE, Cameron JM. Lamivudine inhibits hepatitis B virus (HBV) production in the HBV transfected cell line 2.2.15 [Abstract]. Sixth International Symposium on Viral Hepatitis. Madrid: International Symposium on Viral Hepatitis; 1994: 65.
17. McDonald JA, Caruso L, Karayiannis P, Scully LJ, Harris JR, Forster GE, et al. Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon. Hepatology. 1987; 7: 719-23.
18. Wong DK, Yim C, Naylor CD, Chen E, Sherman M, Vas S, et al. Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population. Gastroenterology. 1996; 108: 165-71.
19. Demetris AJ, Todo S, Van Thiel DH, Fung JJ, Syns G, Ming W, Kakizoe S and Starzl TE. Evolution of hepatitis B virus (HBV) liver disease after hepatic replacement: Practical and theoretical considerations. Am J Pathol 1990; 137: 667-676.
20. Todo S, Demetris AJ, Van Thiel DH, Tepperman L, Fung JJ and Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus (HBV) related liver disease. Hepatology 1991; 13: 619-626.
21. O'Grady JG, Smith HM, Davies SE et al. Hepatitis B virus reinfection after orthotopic liver transplantation. J Hepatol 1992; 14: 104-111.
22. Gish RG, Keeffe EB, Lim J, Brooks IJ, Esquivel CO. Survival alter liver transplantation for chronic hepatitis using reduced immunosuppression. J Hepatol 1995; 22: 257-262.
23. Davies S, Portmann D, O'Grady J et al. Hepatic histological findings after liver transplantation for chronic hepatitis B virus infection including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991; 13: 150-157.
24. Mason AC, Wick M, White HM et al. Increased hepatocyte expression of hepatitis B transcription in patients with features of fibrosing cholestatic hepatitis. Gastroenterology 1993; 105: 237-244.
25. Lau JYN, Bain VG, Davies SE, O'Grady JG, Alberti A, Alexander GJM, Williams R. High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992; 102: 956-962.